James Cruse
Family Medicine · Honesdale, PANPI 1376507517
Payments from drug & device makers
Across 483 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- Novo Nordisk$1K
- AbbVie$893
- GSK$776
- Pfizer$718
- AstraZeneca$591
- plus $3K from 46 others
What the payments were for
- Food & beverage$8,274100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,276 in reported general payments places this provider in the 90th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 106 | $128,185 |
| EliquisApixaban | 167 | $112,263 |
| TrulicityDulaglutide | 42 | $47,738 |
| JardianceEmpagliflozin | 57 | $43,689 |
| MounjaroTirzepatide | 33 | $42,303 |
| FarxigaDapagliflozin Propanediol | 44 | $40,837 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 54 | $39,090 |
| XareltoRivaroxaban | 36 | $34,572 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 59 | $31,597 |
| TradjentaLinagliptin | 20 | $21,428 |
| Repatha SureclickEvolocumab | 22 | $16,201 |
| JanuviaSitagliptin Phosphate | 12 | $15,021 |
| MyrbetriqMirabegron | 16 | $14,500 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $11,886 |
| Breo ElliptaFluticasone/Vilanterol | 22 | $8,835 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,070 | $128,185106 claims |
| PfizerEliquis | $718 | $112,263167 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $488 | $90,04275 claims |
| Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat, Glyxambi | $220 | $79,62199 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $776 | $79,522135 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Bevespi Aerosphere | $591 | $58,66871 claims |
| Johnson & JohnsonXarelto | $101 | $34,57236 claims |
| MerckJanuvia | $173 | $15,02112 claims |
| Astellas Pharma US IncMyrbetriq | $106 | $14,50016 claims |
| AbbVieSynthroid | $893 | $2,60220 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Honesdale
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.